BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23242575)

  • 1. Evolving changes in the management of early oesophageal adenocarcinoma in a tertiary centre.
    O'Farrell NJ; Reynolds JV; Ravi N; Larkin JO; Malik V; Wilson GF; Muldoon C; O'Toole D
    Ir J Med Sci; 2013 Sep; 182(3):363-9. PubMed ID: 23242575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry.
    Haidry RJ; Butt MA; Dunn JM; Gupta A; Lipman G; Smart HL; Bhandari P; Smith L; Willert R; Fullarton G; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Kapoor N; Hoare J; Narayanasamy R; Ang Y; Veitch A; Ragunath K; Novelli M; Lovat LB;
    Gut; 2015 Aug; 64(8):1192-9. PubMed ID: 25539672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eliminating a need for esophagectomy: endoscopic treatment of Barrett esophagus with early esophageal neoplasia.
    Lada MJ; Watson TJ; Shakoor A; Nieman DR; Han M; Tschoner A; Peyre CG; Jones CE; Peters JH
    Semin Thorac Cardiovasc Surg; 2014; 26(4):274-84. PubMed ID: 25837538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia.
    Subramaniam S; Kandiah K; Chedgy F; Meredith P; Longcroft-Wheaton G; Bhandari P
    Dis Esophagus; 2018 Mar; 31(3):. PubMed ID: 29211875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To investigate outcomes in endoscopic management of early oesophageal adenocarcinoma in Barrett oesophagus: experience at three Australian tertiary centres.
    Pateria P; Chong A; Muwanwella N; Siah C; Kumarasinghe P; Raftopoulos S
    Intern Med J; 2022 Apr; 52(4):633-639. PubMed ID: 33073906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
    Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
    Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis.
    Desai M; Saligram S; Gupta N; Vennalaganti P; Bansal A; Choudhary A; Vennelaganti S; He J; Titi M; Maselli R; Qumseya B; Olyaee M; Waxman I; Repici A; Hassan C; Sharma P
    Gastrointest Endosc; 2017 Mar; 85(3):482-495.e4. PubMed ID: 27670227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Visser M; Ten Kate FJ; van Berge Henegouwen MI; Schoon EJ; Weusten BL; Bergman JJ
    Endoscopy; 2012 Dec; 44(12):1096-104. PubMed ID: 23108809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
    Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
    Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical and endoscopic management of high grade dysplasia and early oesophageal adenocarcinoma.
    Le Page PA; Velu PP; Penman ID; Couper GW; Paterson-Brown S; Lamb PJ
    Surgeon; 2016 Dec; 14(6):315-321. PubMed ID: 25744636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
    Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW;
    Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial.
    van Vilsteren FG; Pouw RE; Seewald S; Alvarez Herrero L; Sondermeijer CM; Visser M; Ten Kate FJ; Yu Kim Teng KC; Soehendra N; Rösch T; Weusten BL; Bergman JJ
    Gut; 2011 Jun; 60(6):765-73. PubMed ID: 21209124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endoscopic mucosal resection (EMR) followed by radiofrequency ablation (RFA) in neoplastic Barrett's esophagus or Barrett early cancer is also economically superior to sole radical endoscopic resection].
    Wilke M; Rathmayer M; Schenker M; Schepp W
    Z Gastroenterol; 2016 May; 54(5):416-20. PubMed ID: 27171331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett's esophagus: results from the United States Radiofrequency Ablation Registry.
    Li N; Pasricha S; Bulsiewicz WJ; Pruitt RE; Komanduri S; Wolfsen HC; Chmielewski GW; Corbett FS; Chang KJ; Shaheen NJ
    Dis Esophagus; 2016 Aug; 29(6):537-43. PubMed ID: 26121935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of endoscopic treatment modalities for Barrett's neoplasia.
    David WJ; Qumseya BJ; Qumsiyeh Y; Heckman MG; Diehl NN; Wallace MB; Raimondo M; Woodward TA; Wolfsen HC
    Gastrointest Endosc; 2015 Nov; 82(5):793-803.e3. PubMed ID: 26071064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
    Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II).
    Phoa KN; Pouw RE; Bisschops R; Pech O; Ragunath K; Weusten BL; Schumacher B; Rembacken B; Meining A; Messmann H; Schoon EJ; Gossner L; Mannath J; Seldenrijk CA; Visser M; Lerut T; Seewald S; ten Kate FJ; Ell C; Neuhaus H; Bergman JJ
    Gut; 2016 Apr; 65(4):555-62. PubMed ID: 25731874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.